inquiry@healthyinc.co.in Export: +91-7400209539 +91-9833110409
Warfarin Tablets

Warfarin Tablets

Category: Therapy > Hypertension Tablets
Product Name Warfarin Tablets

Short Description

Product Composition & Strengths

We supply this product in standardized, color-coded strengths to ensure precise dose titration, which is physically critical for this medication.

Active Ingredient Strength Primary Clinical Target
Warfarin Sodium IP/BP/USP 1 mg Micro-Titration: For fine-tuned adjustments.
Warfarin Sodium IP/BP/USP 2 mg Standard Maintenance: For stable anticoagulation.
Warfarin Sodium IP/BP/USP 5 mg High Dose: For initial loading or resistant cases.

Full Description

Warfarin Tablets

Warfarin Sodium Tablets (1 mg / 2 mg / 5 mg)

Healthy Inc is a specialized global supplier and exporter of advanced cardiology, hematology, and critical care therapeutics. We provide ultra-high-purity, kinetically stable Warfarin Sodium Tablets, manufactured in WHO–GMP certified, high-precision pharmaceutical facilities. This "Vitamin K Antagonist (VKA)" is a high-value strategic export to cardiac centers, hospital pharmacies, and international B2B distributors, serving as the globally preferred intervention for the long-term management of thromboembolic disorders.

Product Overview

This formulation operates as a "Clotting Factor Suppressor." It ensures patient safety by chemically interfering with the liver's ability to process Vitamin K, physically preventing the formation of obstructive blood clots.

  • Mechanism 1 (Vitamin K Reductase Inhibition): Warfarin physically inhibits the enzyme Vitamin K Epoxide Reductase. This chemically stops the recycling of Vitamin K.

  • Mechanism 2 (Factor Depletion): By limiting Vitamin K, the body physically cannot produce active Clotting Factors II, VII, IX, and X. This chemically increases the time it takes for blood to clot.

  • Mechanism 3 (Thrombus Prevention): By physically keeping the blood in a less coagulable state, it chemically prevents Strokes, Heart Attacks, and Deep Vein Thrombosis (DVT) in high-risk patients.

Product Composition & Strengths

We supply this product in standardized, color-coded strengths to ensure precise dose titration, which is physically critical for this medication.

Active Ingredient Strength Primary Clinical Target
Warfarin Sodium IP/BP/USP 1 mg Micro-Titration: For fine-tuned adjustments.
Warfarin Sodium IP/BP/USP 2 mg Standard Maintenance: For stable anticoagulation.
Warfarin Sodium IP/BP/USP 5 mg High Dose: For initial loading or resistant cases.

Technical & Logistics Specifications

  • HS Code: 3004.90.99 (Medicaments acting on the blood / Others)

  • CAS Number: 129-06-6 (Warfarin Sodium)

  • Dosage Form: Oral Tablet (Scored for easy splitting)

  • Packaging: 10 or 28 Tablets per Blister in high-barrier Alu-Alu or PVC/PVDC. Our specialized packaging ensures 36-month stability in Zone IVb tropical climates.

Manufacturing Authority & Compliance

  • Dose Uniformity Precision: Warfarin has a Narrow Therapeutic Index, meaning even micro-gram variations can be physically dangerous. Our manufacturing process utilizes Automated High-Precision Blending, physically ensuring every tablet contains the exact chemical dose.

  • Batch-to-Batch Bioequivalence: We utilize Comparative Dissolution Profiling, physically ensuring our tablets are chemically bioequivalent to the innovator brand (Coumadin), a critical factor for specialists switching patient medications.

  • Stability Validation: We utilize Climate-Controlled Production, physically ensuring the chemical integrity of the sodium salt remains stable during international transit to humid regions.

Primary Indications

  • Cardiology: Prevention of systemic embolism in patients with Mechanical Heart Valves or Atrial Fibrillation.

  • Hematology: Treatment and prevention of Deep Vein Thrombosis (DVT) and Pulmonary Embolism (PE).

  • Neurology: Reduction of the risk of recurrent Stroke and transient ischemic attacks.

Usage Instructions

  • Administration: Swallow the tablet physically whole at the same time every day.

  • Dietary Note: Patients must physically maintain a consistent Vitamin K intake (leafy greens). Sudden changes in diet can chemically interfere with Warfarin’s efficacy.

  • Monitoring: Regular INR (International Normalized Ratio) blood tests are physically mandatory to chemically adjust the dosage.

  • Symptom Awareness: Patients should physically report any unusual bruising or prolonged bleeding immediately.

Safety Warning: CRITICAL ANTICOAGULANT. Bleeding Risk: May physically cause major or fatal bleeding; monitor INR levels chemically. Pregnancy Note: STRICT CONTRAINDICATION: Warfarin physically causes Severe Birth Defects; do not use in pregnant women. Contraindication: Do not use in patients with active bleeding, severe hypertension, or known hypersensitivity to Warfarin.

Global Export & Contract Manufacturing

Healthy Inc is a premier Cardiovascular and Hematology Pharmaceutical Exporter in India. As a verified Medicine Supplier in Mumbai, we offer flexible Third Party Manufacturing (Contract Manufacturing) for high-volume Warfarin tablets. Whether you are a National Cardiac Center in the CIS or a B2B Pharma Marketplace partner in Africa or SE Asia, we ensure secure, WHO-GMP compliant delivery.

Commercial Inquiries:

WhatsApp/Call: +91 7710003340

Email: info@healthyinc.co.in

Related Products